These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22087827)

  • 1. Nanostructures for drug delivery to the brain.
    Martin-Banderas L; Holgado MA; Venero JL; Alvarez-Fuentes J; Fernández-Arévalo M
    Curr Med Chem; 2011; 18(34):5303-21. PubMed ID: 22087827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue?
    Ricci M; Blasi P; Giovagnoli S; Rossi C
    Curr Med Chem; 2006; 13(15):1757-75. PubMed ID: 16787219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly organized nanostructures for brain drug delivery--new hope or just a fad?
    Labuzek K; Gorki K; Jaroszek H; Jarzabek K; Gabryel B; Okopien B
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1271-85. PubMed ID: 24040789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
    Goyal K; Koul V; Singh Y; Anand A
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-brain barrier and brain drug delivery.
    Koziara JM; Lockman PR; Allen DD; Mumper RJ
    J Nanosci Nanotechnol; 2006; 6(9-10):2712-35. PubMed ID: 17048477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
    Crawford L; Rosch J; Putnam D
    J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
    Xie J; Shen Z; Anraku Y; Kataoka K; Chen X
    Biomaterials; 2019 Dec; 224():119491. PubMed ID: 31546096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research advances in brain-targeted nanoscale drug delivery system].
    Liu Y; Jiang C
    Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
    Kreuter J
    J Nanosci Nanotechnol; 2004 May; 4(5):484-8. PubMed ID: 15503433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New technologies for drug delivery across the blood brain barrier.
    Kabanov AV; Batrakova EV
    Curr Pharm Des; 2004; 10(12):1355-63. PubMed ID: 15134486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.
    Denora N; Trapani A; Laquintana V; Lopedota A; Trapani G
    Curr Top Med Chem; 2009; 9(2):182-96. PubMed ID: 19200004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
    Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
    Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for drug delivery to the central nervous system by systemic route.
    Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
    Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system delivery of molecules across the blood-brain barrier.
    Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
    Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS; Ramaiyan V; Sukumaran SK
    Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon nanostructures: The drug and the delivery system for brain disorders.
    Henna TK; Raphey VR; Sankar R; Ameena Shirin VK; Gangadharappa HV; Pramod K
    Int J Pharm; 2020 Sep; 587():119701. PubMed ID: 32736018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crossing the blood-brain barrier with nanoparticles.
    Zhou Y; Peng Z; Seven ES; Leblanc RM
    J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.